Total amount: € 0,00
Official Journal of the Italian Society of Thoracic Endoscopy
Indexed/Abstracted in: EMBASE, Scopus
Online ISSN 1827-1723
Rossi D., Alessandroni P., Luzi Fedeli S., Fedeli A., Giordani P., Catalano V., Baldelli A. M., Catalano G.
This case report concerns a patient with atypical lung carcinoid with liver and bone metastases successfully treated for over 2 years with LAR octreotide. This patient underwent right bilobectomy with mediastinal adenectomy in 1996. In January 2000, the instrumental evaluation showed a disease progression on liver and bone. After only 1 cycle with cisplatin/etoposide, the patient stopped chemotherapy and started the administration of octreotide LAR (1 i.m. injection every month) for a prolonged sternal pain suspected for angina pectoris. Up to date, this drug allowed to control this neoplasm with no side effects and optimal impact on the patient's quality of life. LAR octreotide is a highly manageable drug and may be used as first approach in this neoplasm, particularly in the elderly or in the presence of clinical impairment.